CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-01-13 | Chin Richard Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2011-01-13 | Ahn Mark J Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2010-12-29 | CYTRX CORP 10% owner | Sale | −2,593,881 | $2.20 | $5.7M | 0 |
| 2010-12-22 | CYTRX CORP 10% owner | Sale | −500,000 | $2.65 | $1.3M | 2,593,881 |
| 2010-07-19 | Varanasi Ramani VP Business Development | Sale | −5,000 | $2.05 | $10K | 5,558 |
| 2010-07-19 | Varanasi Ramani VP Business Development | Grant or award | +5,600 | $2.04 | $11K | 11,158 |
| 2010-07-15 | Pavco Pamela VP of Pharmaceutical Devlpmt. | Grant or award | +5,000 | $2.38 | $12K | 11,377 |
| 2010-07-12 | Khvorova Anastasia Chief Science Officer | Grant or award | +10,000 | $2.23 | $22K | 17,506 |
| 2010-07-09 | Beerman Noah D CEO and President | Purchase | +10,000 | $2.23 | $22K | 15,407 |
| 2010-07-08 | Varanasi Ramani VP Business Development | Grant or award | +5,000 | $2.04 | $10K | 10,558 |
| 2010-06-30 | CYTRX CORP 10% owner | Sale | −2,000,000 | $2.55 | $5.1M | 3,093,881 |
| 2010-04-15 | Varanasi Ramani VP Business Development | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2010-04-15 | Pavco Pamela VP of Pharmaceutical Devlpmt. | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2010-04-15 | Khvorova Anastasia Chief Science Officer | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2010-04-15 | Andrikopoulos Konstantinos VP, Legal | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2010-03-31 | Samarsky Dmitry VP, Technology Development | Sale | −4,081 | $4.65 | $19K | 0 |
| 2010-03-26 | CYTRX CORP 10% owner | Sale | −675,000 | $5.70 | $3.8M | 5,093,881 |
| 2010-03-26 | Hillsberg Sanford Director | Sale | −25,000 | $5.66 | $142K | 6,000 |
| 2010-03-26 | GALLIKER STEPHEN S Director | Sale | −15,000 | $5.54 | $83K | 10,000 |
| 2010-03-02 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option | +50,000 | 50,000 |
Page 22 of 29 · 580 trades